Wanatsanan Chulrik

8PUBLICATIONS
22CO-AUTHORS
Characterisation of biological macromoleculesCardiovascular medicine and haematology not elsewhere classifiedMolecular medicineToxicology (incl. clinical toxicology)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 15, 2026
6β-Acetoxysandaracopimaradien-1α,9α-diol Attenuates LPS-Induced Acute Lung Injury: Association with Alterations in Src, MAPK, and Akt/GSK-3β Signalling.

|Apr 27, 2026
Association of ABO and Rh blood groups with hepatitis C virus infection: a systematic review and meta-analysis.

|Feb 12, 2026
Mechanistic insights into the anti-inflammatory effects of isocoronarin D associated with reduced PKCδ and PI3K/Akt signalling in LPS-activated macrophages.

Wanatsanan Chulrik, Rungruedee Kimseng, Chutima Jansakun

|Jan 21, 2026
In Silico Investigation Reveals IL-6 as a Key Target of Asiatic Acid in Osteoporosis: Insights from Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation.

Wanatsanan Chulrik, Aman Tedasen, Nateelak Kooltheat

|May 02, 2023
Protective effects of Stephania pierrei tuber-derived oxocrebanine against LPS-induced acute lung injury in mice.

Wanatsanan Chulrik, Chutima Jansakun, Waraluck Chaichompoo

|Dec 29, 2022
Trihydroxyxanthones from the heartwood of Maclura cochinchinensis modulate M1/M2 macrophage polarisation and enhance surface TLR4.

Chutima Jansakun, Wanatsanan Chulrik, Janejira Hata

Pageof 2

Frequent Collaborators

6 joint publications

Chutima Jansakun

6 joint publications

Warangkana Chunglok

5 joint publications

Aman Tedasen

5 joint publications

Apichart Suksamrarn